Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis

AUTOR(ES)

Tuon, Felipe Francisco, Guastini, Cristina Maria de Fátima, Boulos, Maria Ivete Castro

FONTE

Brazilian Journal of Infectious Diseases

DATA DE PUBLICAÇÃO

2008-08

RESUMO

Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.

Documentos Relacionados

• Lamivudine therapy for hepatitis B in renal transplantation
• Lamivudine for chronic hepatitis B: a brief review
• HBsAg Seroclearance in Chinese Patients Receiving Lamivudine Therapy for Chronic Hepatitis B Virus Infection
• Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
• Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes